Year: 2025

HOUSTON, TX, June 09, 2025 (GLOBE NEWSWIRE) — Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”), an independent energy company engaged in the development and acquisition of oil and natural gas resources in the Denver-Julesburg (DJ) Basin, today announced the reaffirmation of its multi-year Reserve-Based Lending (“RBL”) credit facility with Citibank, N.A., its lead arranger. Following its semi-annual redetermination, the Company’s reserve-based credit facility was reaffirmed with a borrowing base of $475 million, a maximum facility size of $1.0 billion, and a maturity date of March 26, 2029. “The reaffirmation of our borrowing base, along with the addition of Bank of America and West Texas National Bank to our syndicate, underscores the confidence our lenders have in the strength of our asset base and execution...

TORONTO, ON, June 09, 2025 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV:FW) (“Flow Capital” or the “Company”) is pleased to announce the successful closing of a US$5.0 million secured loan investment in a leading US-based hospitality management company and technology platform. The investment is part of a broader US$50 million senior secured unitranche loan transaction with a consortium of lenders led by Beedie Investments Ltd. (“Beedie Capital”), which is also the administrative and collateral agent. This transaction underscores Flow Capital’s continued momentum as a preferred partner for both high-growth companies across North America and leading institutional capital providers in the space. Technology companies seeking covenant-light, founder-friendly growth capital are invited to apply for funding directly at www.flowcap.com/get-funding.  About...

VANCOUVER, British Columbia, June 09, 2025 (GLOBE NEWSWIRE) — Ranchero Gold Corp. (“Ranchero” or the “Company”) (TSX.V:RNCH) is pleased to announce the appointment of Andrew Wilson as an independent director of the Company and as chair of the Audit Committee of the Company. Mr. Wilson is the founder and director of Stellium, a company providing business development, communication, investor access, and corporate advisory services to growth companies. Prior to founding Stellium, Andrew spent 14 years working in capital markets roles focused primarily on growth companies and natural resources. He has extensive experience in capital raising for mining, oil and gas, and renewable energy businesses both privately and also listed on public exchanges (AIM, TSX and ASX). Previous roles included running the UK office for the independent...

Patent issuance expands United States patent coverage for AVERSA™ transdermal abuse deterrent technology AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents issued in 46 countries including the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia. ORLANDO, Fla., June 09, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that the United States Patent and Trademark Office (USPTO) issued patent number 12,318,492 on June 3, 2025, entitled “Abuse and Misuse Deterrent Transdermal Systems.” The issuance of this patent further expands Nutriband’s intellectual property protection in...

QUEBEC CITY, Canada, June 09, 2025 (GLOBE NEWSWIRE) — LeddarTech® Holdings Inc. (“LeddarTech” or the “Company”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-powered low-level sensor fusion and perception software technology, LeddarVision™, today announced that it has entered into:an eighteenth amending agreement (the “Eighteenth Amending Agreement”) with Fédération des caisses Desjardins du Québec (“Desjardins”) with respect to the amended and restated financing offer dated as of April 5, 2023 (the “Desjardins Credit Facility”), pursuant to which Desjardins has agreed to, among other things, temporarily postpone certain payments of interest and fees until January 31, 2026, subject to acceptable cash flow projected payments; anda sixth amending agreement (the “Sixth Amending Agreement”)...

FDA Orphan Products Grants are awarded based on rigorous scientific and technical review by rare disease and regulatory experts Up to $2.6 million in non-dilutive funding anticipated over the grant period Top-line data from SELVA expected in the first quarter of 2026 WAYNE, Pa., June 09, 2025 (GLOBE NEWSWIRE) — Palvella Therapeutics, Inc. (Nasdaq: PVLA), a clinical-stage biopharmaceutical company developing and commercializing novel therapies for serious, rare genetic skin diseases with no U.S. Food and Drug Administration (FDA)-approved treatments, today announced it has received the initial proceeds from a previously announced grant from the FDA Office of Orphan Products Development. The grant supports the Company’s ongoing Phase 3 SELVA trial of QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment...

TEL AVIV, Israel, June 09, 2025 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of web data collection solutions, today announced an update to its revenue and Adjusted EBITDA outlook for the second quarter ending June 30, 2025, driven by enhanced momentum and demand from several existing customers since the previous guidance date, which has led to a significant increase in usage – resulting in higher-than-anticipated consumption of Alarum’s data collection products and services. The Company now estimates to report second quarter 2025 revenue of approximately $8.8 million ±3%, compared to its previous estimate of $7.9 million ±3%. In addition, the Company now expects to report adjusted EBITDA ranging from $1.0 million to $1.5 million, compared to $0.5 million...

D-PLEX100 successfully met the primary efficacy endpoint, with statistically significant results (p

Plug Power and Allied Green Leadership attending International Investment Forum to Execute the Agreement Allied Green Continues to Make Meaningful Progress in its Green Ammonia Plant in Australia with Plug to supply 3GW of Electrolyzer Capacity Bringing the total opportunity between partners to 5GW globally SLINGERLANDS, N.Y., June 09, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions, today announced a significant expansion of its partnership with Allied Green Ammonia (AGA), with a new 2 gigawatt (GW) electrolyzer opportunity tied to a sustainable fuels project in Uzbekistan. The deal will be executed during the Tashkent International Investment Forum, where Sanjay Shrestha, President of Plug, and Alfred Benedict, Managing Director of Allied Green, will be on site for the...

– New blinded safety and efficacy data from 30 patients in ongoing Phase 2 trial to be unveiled June 13, 2025 – – ISSCR 2025 is the premier global event for stem cell research, drawing nearly 4,000 leaders from academia, biotech, and pharma – – BioRestorative to release new clinical data to the public prior to market open on June 13th – MELVILLE, N.Y., June 09, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical-stage regenerative medicine company developing stem cell-based therapies for serious musculoskeletal conditions, today announced that new preliminary, blinded clinical data from 30 patients enrolled in its ongoing Phase 2 trial of BRTX-100 for the treatment of chronic lumbar disc disease (cLDD) will be presented at the prestigious International Society...